TABLE 2.
Treatment and post-therapy PET/CT evaluation
| Authors | Therapy (n) | Prior nephrectomy (%) | Patients performing post-therapy PET-CT scan | Post-therapy PET scan timing |
|---|---|---|---|---|
| Vercellino et al.22 | Sunitinib (12) | 10 (83) | 12 | 1 cycle |
| Lyrdal et al.19 | Sorafenib (10) | 9 (90) | 10 | 1 cycle |
| Minamimoto et al.24 | Sunitinib (5) Sorafenib (7) |
10 (83) | 12 | 1 cycle |
| Revheim et al.25 | Sunitinib (14) | 13 (93) | 13* | 2 cycles |
| Kayani et al.23 | Sunitinib (44) | No | 43** | 1 cycle (43 pts) 3 cycles (39 pts) |
| Ueno et al.20 | Sunitinib (16) Sorafenib (14) |
22 (73) | 30 | 1 cycle |
| Khandani et al.18 | Sorafenib (26) | No | 17 | 1 cycle |
* Not performed in 1 patient because of rapid status deterioration
** Not performed in 1 patient because of negative baseline scan